Bronchodilator

The odds for bronchodilator responsiveness significantly fell among patients who underwent spirometry testing in the afternoon vs. morning, according to findings published in Thorax.

BOSTON — Combined treatments were associated with reduced asthma exacerbations compared with short-acting beta agonists alone, based on a review presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

WASHINGTON — Showing more improvement in bronchodilator responsiveness testing was linked to more exacerbations, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Black children were more likely to require EMS and receive bronchodilator treatment for an asthma episode than white children, but were less likely to receive EMS transport, according to a study published in Prehospital Emergency Care.

Patients with COPD first visiting the ED with acute exacerbations faced greater risks for dementia with ICU admission vs. hospital admission or exclusive ED care, according to study results published in BMC Pulmonary Medicine.

In late October 2022, the FDA declared a shortage of albuterol sulfate inhalation solution 0.5%, and as of early April the shortage is still in effect, according to the administration’s website.

Patients with asthma and insulin resistance had lower and faster loss of lung function, as well as suboptimal responses to asthma treatments, according to a study published in American Journal of Respiratory and Critical Care Medicine.

Patients with COPD experienced early, but modest and nonpersistent, reductions in lung function during treatment with metoprolol, according to a post-hoc analysis of the BLOCK COPD study in The Annals of the American Thoracic Society.

Daily inhaled corticosteroid and bronchodilator therapy may help children with reversible peripheral airway obstruction and lung hyperinflation after developing persistent dyspnea despite normal spirometry, according to a recent case study.

Individuals with pre-bronchodilator airflow obstruction appeared to be at significant risk for future COPD development, researchers reported in the American Journal of Respiratory and Critical Care Medicine.